The Weight Loss Showdown: Semaglutide vs. Tirzepatide Head-to-Head Study: IM Grand Rounds

Claim CME Credit https://www.surveymonkey.com/r/FMCQTDB Speaker Nawras Silin, MD PGY3 Internal Medicine Resident Learning Objectives Compare the effectiveness of tirzepatide vs. semaglutide on weight loss. Evaluate the safety profiles of semaglutide and tirzepatide, focusing on the incidence of gastrointestinal adverse events. Interpret study limitations and their implications on findings for clinical practice. Apply the study findings into clinical practice, while considering the patient’s comorbidities. Financial Disclosures None Expiration Date 9/13/26 Accreditation Statement The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. If you have technical difficulties or questions contact [email protected]